1. 059 A phase 3, randomised controlled trial comparing upadacitinib monotherapy to MTX monotherapy in MTX-naïve patients with active rheumatoid arthritis. (12th April 2019) Authors: van Vollenhoven, R; Takeuchi, T; Pangan, A L; Friedman, A; Mohamed, M F; Chen, S; Rischmueller, M; Blanco, R; Xavier, R M; Strand, V Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Epistasis between the MHC and the RCAα block in primary Sjögren syndrome. Issue 6 (18th September 2007) Authors: Lester, S; McLure, C; Williamson, J; Bardy, P; Rischmueller, M; Dawkins, R L Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 6(2008) Page Start: 849 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Fas gene promoter polymorphisms in primary Sjögren's syndrome. Issue 1 (12th December 2003) Authors: Mullighan, C G; Heatley, S; Lester, S; Rischmueller, M; Gordon, T P; Bardy, P G Journal: Annals of the rheumatic diseases Issue: Volume 63:Issue 1(2004) Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0003 High dose chemotherapy without autologous stem cell reinfusion in the treatment of ra. (1st June 2001) Authors: Pile, KD; Rischmueller, M; Milazzo, L; Jaksic, W; Wickham, N Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0302 Analysis of 9302 patients from the big data international primary sjÖgren syndrome cohort: clinical presentation at diagnosis of european vs non-european patients. (15th June 2017) Authors: Brito-Zerόn, P; Acar-Denizli, N; Zeher, M; Rasmussen, A; Seror, R; Mandl, T; Li, X; Baldini, C; Gottenberg, J-E; Danda, D; Priori, R; Quartuccio, L; Hernandez-Molina, G; Kruize, AA; Park, S-H; Kvarnström, M; Praprotnik, S; Sene, D; Bartoloni, E; Solans, R Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 886 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0284 Predicting survival in 6240 patients with primary sjÖgren' syndrome (big data sjÖgren project). (15th June 2017) Authors: Brito-Zerόn, P; Acar-Denizli, N; Zeher, M; Rasmussen, A; Li, X; Baldini, C; Gottenberg, J-E; Danda, D; Quartuccio, L; Hernandez-Molina, G; Kruize, AA; Park, S-H; Kvarnström, M; Praprotnik, S; Sene, D; Bartoloni, E; Solans, R; Mandl, T; Suzuki, Y; Rischmueller, M Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0464 A genome-wide association study of gout in people of european ancestry. (15th June 2017) Authors: Merriman, TR; Cadzow, M; Merriman, M; Phipps-Green, A; Topless, R; Abhishek, A; Andres, M; Bradbury, L; Buchanan, R; Cremin, K; Guzman, E de; Zoysa, J de; Doherty, M; Hill, C; Huizinga, T; Jansen, T; Janssen, M; Joosten, L; Kurreeman, F; Lester, S Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. THU0681 Baseline ESSDAI/DAS scores in 8061 patients with primary sjÖgren syndrome: characterization of systemic disease. (15th June 2017) Authors: Brito-Zerόn, P; Acar-Denizli, N; Zeher, M; Rasmussen, A; Li, X; Baldini, C; Gottenberg, J-E; Danda, D; Quartuccio, L; Hernandez-Molina, G; Kruize, AA; Park, S-H; Kvarnström, M; Praprotnik, S; Sene, D; Alunno, A; Solans, R; Mandl, T; Suzuki, Y; Rischmueller, M Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 464 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus. (November 2018) Authors: Vincent, F B; Kandane-Rathnayake, R; Hoi, A Y; Slavin, L; Godsell, J D; Kitching, A R; Harris, J; Nelson, C L; Jenkins, A J; Chrysostomou, A; Hibbs, M L; Kerr, P G; Rischmueller, M; Mackay, F; Morand, E F Journal: Lupus Issue: Volume 27:Number 13(2018) Page Start: 2029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗